10月5日，今海医疗科技（HK2225）(02225.HK)盘中跌超5%，截至13时34分，跌5.77%，报4.66港元/股，成交额468.60万港元。消息面上，公司于9月7日获纳入港股通，北水持股比例由0.3%增至0.7%。上半年微创手术等医疗收入2543万新加坡元，同比增301.5%，全部来自中国并首次计提中国企业所得税。公司委任刘金晶为独立非执行董事，李云平、杨美华辞任。中期收益增至3400...
Source Link10月5日，今海医疗科技（HK2225）(02225.HK)盘中跌超5%，截至13时34分，跌5.77%，报4.66港元/股，成交额468.60万港元。消息面上，公司于9月7日获纳入港股通，北水持股比例由0.3%增至0.7%。上半年微创手术等医疗收入2543万新加坡元，同比增301.5%，全部来自中国并首次计提中国企业所得税。公司委任刘金晶为独立非执行董事，李云平、杨美华辞任。中期收益增至3400...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.